A Children's Oncology Group Protocol for Collecting and Banking Pediatric Research Specimens including Rare Pediatric Tumors.

Protocol for the Enrollment on the Official COG Registry, the Childhood Cancer Research Network (CCRN)

Umbrella Long-term Follow-up Protocol

PALLAS: PALbociclib CoLlaborative Adjuvant Study: A Randomized Phase III Trial of Palbociclib With Standard Adjuvant Endocrine Therapy Versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive (HR+) / Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Early Breast Cancer

A Single Arm Phase II Study of Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-016

A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination with Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BTCRC-BRE15-024

Children's Lives Include Moments of Bravery (CLIMB)

Role of TRP Channel Isoforms in Breast Cancer

Patterns of Patient Care in Appalachia

An Observational Trial of the Phase I and II Metabolism Profile of Exemestane in Breast Cancer Patients

Clinicopathologic Study of Breast Cancer

Sirtuin 3 (SIRT3): A Novel Predictive Biomarker for Tamoxifen Resistance

Predicting Breast Cancer Metastasis: Signaling Pathway Biomarker Identification Using Reverse Phase Protein Microarray (RPMA) Technology

Protocol for a Research Database for Hematopoietic Cell Transplantation, other Cellular Therapies and Marrow Toxic Injuries.